ARCHIVES

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Considering DRCCA Request to Fund More CCOPs for Better Distribution; Some Will Be Rereviewed

August 19, 1983

Senate Committee Approves $27 Billion for NIH, $4.6 Billion for NCI

August 2, 2002

Michelle Le Beau named director of University of Chicago Cancer Research Center.

May 7, 2004

Report Calls For Reinvigorated Cancer Program With Increased Funding, Greater Collaboration.

May 9, 2008

Funding Opportunities: CAM Research Center Applications Sought.

January 3, 2003

STAR completes enrollment.

July 30, 2004